141 related articles for article (PubMed ID: 11677953)
1. Less reversal of liver fibrosis after prolonged carbon tetrachloride injection.
Lee HS; Huang GT; Chen CH; Chiou LL; Lee CC; Yang PM; Chen DS; Sheu JC
Hepatogastroenterology; 2001; 48(41):1312-5. PubMed ID: 11677953
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases in spontaneous regression of liver fibrosis.
Lee HS; Huang GT; Miau LH; Chiou LL; Chen CH; Sheu JC
Hepatogastroenterology; 2001; 48(40):1114-7. PubMed ID: 11490813
[TBL] [Abstract][Full Text] [Related]
3. Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2009 Jun; 234(6):662-5. PubMed ID: 19307461
[TBL] [Abstract][Full Text] [Related]
4. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production.
Hisamori S; Tabata C; Kadokawa Y; Okoshi K; Tabata R; Mori A; Nagayama S; Watanabe G; Kubo H; Sakai Y
Liver Int; 2008 Nov; 28(9):1217-25. PubMed ID: 18397230
[TBL] [Abstract][Full Text] [Related]
5. [The role of changes of MMP-2, 9 activity in the development of liver fibrosis in rats].
Wang XB; Liu P; Tang ZP; Lu X; Liu CH; Hu YY; Xu LM; Gu HT; Liu C
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):267-70. PubMed ID: 15161499
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
[TBL] [Abstract][Full Text] [Related]
7. [Immune complex induced rat liver fibrosis model by intraperitoneal injection of human serum albumin].
Dong Z; Liu J; Shen H; Ma H; Jia JD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):12-5. PubMed ID: 16642209
[TBL] [Abstract][Full Text] [Related]
8. Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents.
Zhao XY; Wang BE; Li XM; Wang TL
Pathol Int; 2008 Sep; 58(9):580-8. PubMed ID: 18801073
[TBL] [Abstract][Full Text] [Related]
9. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
Higashiyama R; Inagaki Y; Hong YY; Kushida M; Nakao S; Niioka M; Watanabe T; Okano H; Matsuzaki Y; Shiota G; Okazaki I
Hepatology; 2007 Jan; 45(1):213-22. PubMed ID: 17187438
[TBL] [Abstract][Full Text] [Related]
12. Platelets contribute to the reduction of liver fibrosis in mice.
Watanabe M; Murata S; Hashimoto I; Nakano Y; Ikeda O; Aoyagi Y; Matsuo R; Fukunaga K; Yasue H; Ohkohchi N
J Gastroenterol Hepatol; 2009 Jan; 24(1):78-89. PubMed ID: 18624898
[TBL] [Abstract][Full Text] [Related]
13. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice.
Chen C; Zhang J; Li J; Huang J; Yang C; Huang G; Shi J
Liver Int; 2004 Dec; 24(6):679-86. PubMed ID: 15566521
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis.
Zhou X; Hovell CJ; Pawley S; Hutchings MI; Arthur MJ; Iredale JP; Benyon RC
Liver Int; 2004 Oct; 24(5):492-501. PubMed ID: 15482348
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.
Horani A; Muhanna N; Pappo O; Melhem A; Alvarez CE; Doron S; Wehbi W; Dimitrios K; Friedman SL; Safadi R
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G628-38. PubMed ID: 17038628
[TBL] [Abstract][Full Text] [Related]
16. Hepatic prolyl hydroxylase activity in experimental cirrhosis.
McPhie JL; Short LT
Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):387-91. PubMed ID: 174370
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic evolution of MMP-2 gene expression and its enzymatic activities in experimental liver fibrosis].
Zhu YK; Wang BE; Shen FJ; Jia JD; Ma H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):509-12. PubMed ID: 16042886
[TBL] [Abstract][Full Text] [Related]
18. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats.
Sun WY; Wei W; Wu L; Gui SY; Wang H
J Ethnopharmacol; 2007 Jul; 112(3):514-23. PubMed ID: 17574357
[TBL] [Abstract][Full Text] [Related]
19. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.
Chou WY; Lu CN; Lee TH; Wu CL; Hung KS; Concejero AM; Jawan B; Wang CH
Acta Pharmacol Sin; 2006 Apr; 27(4):469-76. PubMed ID: 16539848
[TBL] [Abstract][Full Text] [Related]
20. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice.
Natsume M; Tsuji H; Harada A; Akiyama M; Yano T; Ishikura H; Nakanishi I; Matsushima K; Kaneko S; Mukaida N
J Leukoc Biol; 1999 Oct; 66(4):601-8. PubMed ID: 10534116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
